NRC Health Statistics
Total Valuation
NRC Health has a market cap or net worth of $431.94 million. The enterprise value is $518.64 million.
| Market Cap | 431.94M |
| Enterprise Value | 518.64M |
Important Dates
The last earnings date was Tuesday, July 28, 2026, after market close.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | Sep 25, 2026 |
Share Statistics
NRC Health has 22.14 million shares outstanding. The number of shares has decreased by -5.38% in one year.
| Current Share Class | 22.14M |
| Shares Outstanding | 22.14M |
| Shares Change (YoY) | -5.38% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 46.54% |
| Owned by Institutions (%) | 52.73% |
| Float | 11.84M |
Valuation Ratios
The trailing PE ratio is 81.16 and the forward PE ratio is 20.54.
| PE Ratio | 81.16 |
| Forward PE | 20.54 |
| PS Ratio | 3.09 |
| Forward PS | 2.93 |
| PB Ratio | 65.95 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 19.96 |
| P/OCF Ratio | 14.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.19, with an EV/FCF ratio of 23.97.
| EV / Earnings | 93.45 |
| EV / Sales | 3.70 |
| EV / EBITDA | 22.19 |
| EV / EBIT | 35.19 |
| EV / FCF | 23.97 |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 13.75.
| Current Ratio | 0.65 |
| Quick Ratio | 0.36 |
| Debt / Equity | 13.75 |
| Debt / EBITDA | 3.85 |
| Debt / FCF | 4.16 |
| Interest Coverage | 2.73 |
Financial Efficiency
Return on equity (ROE) is 42.03% and return on invested capital (ROIC) is 14.75%.
| Return on Equity (ROE) | 42.03% |
| Return on Assets (ROA) | 9.69% |
| Return on Invested Capital (ROIC) | 14.75% |
| Return on Capital Employed (ROCE) | 14.57% |
| Weighted Average Cost of Capital (WACC) | 5.89% |
| Revenue Per Employee | $392,148 |
| Profits Per Employee | $15,546 |
| Employee Count | 357 |
| Asset Turnover | 1.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRC Health has paid $3.53 million in taxes.
| Income Tax | 3.53M |
| Effective Tax Rate | 37.57% |
Stock Price Statistics
The stock price has increased by +54.47% in the last 52 weeks. The beta is 0.38, so NRC Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +54.47% |
| 50-Day Moving Average | 20.39 |
| 200-Day Moving Average | 17.58 |
| Relative Strength Index (RSI) | 42.73 |
| Average Volume (20 Days) | 90,654 |
Short Selling Information
The latest short interest is 520,821, so 2.35% of the outstanding shares have been sold short.
| Short Interest | 520,821 |
| Short Previous Month | 468,676 |
| Short % of Shares Out | 2.35% |
| Short % of Float | 4.40% |
| Short Ratio (days to cover) | 4.68 |
Income Statement
In the last 12 months, NRC Health had revenue of $140.00 million and earned $5.55 million in profits. Earnings per share was $0.24.
| Revenue | 140.00M |
| Gross Profit | 86.45M |
| Operating Income | 21.53M |
| Pretax Income | 9.38M |
| Net Income | 5.55M |
| EBITDA | 23.37M |
| EBIT | 14.74M |
| Earnings Per Share (EPS) | $0.24 |
Balance Sheet
The company has $3.33 million in cash and $90.03 million in debt, with a net cash position of -$86.70 million or -$3.92 per share.
| Cash & Cash Equivalents | 3.33M |
| Total Debt | 90.03M |
| Net Cash | -86.70M |
| Net Cash Per Share | -$3.92 |
| Equity (Book Value) | 6.55M |
| Book Value Per Share | 0.30 |
| Working Capital | -12.21M |
Cash Flow
In the last 12 months, operating cash flow was $29.51 million and capital expenditures -$7.87 million, giving a free cash flow of $21.64 million.
| Operating Cash Flow | 29.51M |
| Capital Expenditures | -7.87M |
| Depreciation & Amortization | 8.63M |
| Net Borrowing | 8.95M |
| Free Cash Flow | 21.64M |
| FCF Per Share | $0.98 |
Margins
Gross margin is 61.75%, with operating and profit margins of 15.38% and 4.18%.
| Gross Margin | 61.75% |
| Operating Margin | 15.38% |
| Pretax Margin | 6.70% |
| Profit Margin | 4.18% |
| EBITDA Margin | 16.69% |
| EBIT Margin | 10.53% |
| FCF Margin | 15.46% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 3.28%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 3.28% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 266.23% |
| Buyback Yield | 5.38% |
| Shareholder Yield | 8.66% |
| Earnings Yield | 1.28% |
| FCF Yield | 5.01% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRC Health has an Altman Z-Score of 2.92 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.92 |
| Piotroski F-Score | 5 |